Multifocal Extraprostatic Extension of Prostate Cancer: A Third Subtype With Worse Prognosis Than Focal Prostate Cancer

被引:5
|
作者
Farchoukh, Lama [1 ]
LaFramboise, William A. [3 ]
Nelson, Joel B. [2 ]
Bastacky, Sheldon [1 ]
Parwani, Anil, V [4 ]
Dhir, Rajiv [1 ]
机构
[1] Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Urol, Med Ctr, Pittsburgh, PA USA
[3] Allegh Gen Hosp, Dept Pathol, Pittsburgh, PA USA
[4] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
关键词
Prostate cancer; Adenocarcinoma; Extraprostatic extension; Focal extraprostatic extension; Multifocal extraprostatic extension; Extensive extraprostatic extension; Prognosis; ISUP CONSENSUS CONFERENCE; RADICAL PROSTATECTOMY; INTERNATIONAL SOCIETY; RADIAL DISTANCE; TUMOR VOLUME; CARCINOMA; STAGE; PROGRESSION; RECURRENCE; INVASION;
D O I
10.1093/ajcp/aqz193
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To investigate the prognostic utility of multifocal extraprostatic extension (EPE) on biochemical recurrence after radical prostatectomy. Methods: We conducted retrospective analysis of biochemical recurrence and prognostic pathologic variables in 673 men with stage pT3a/pT3b prostate cancer from 2000 to 2012. Extent of EPE on radical prostatectomy was divided into three groups: focal EPE (tumor dimension <0.8 mm), established (>= 0.8 mm), and multifocal (more than one focus of EPE <0.8 mm). Results: Type of EPE had significant effect on recurrence with progressively lower progression-free probability and higher recurrence probability from focal to established to multifocal. Multifocal and established tumors exhibited worse prognostic features and higher hazard ratio than focal. In multivariate analysis, established and multifocal were independent prognostic factors with the greatest adverse prognostic significance associated with multifocal. Conclusions: Identification of multifocal EPE provides important prognostic information associated with increased likelihood of recurrence compared to focal and established tumors.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 50 条
  • [41] Prediction of extraprostatic cancer by serum [-2] pro prostate specific antigen in clinically localized prostate cancer
    Nakashima, Jun
    Yamazaki, Keiichi
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    Ohigashi, Takashi
    Murai, Masaru
    JOURNAL OF UROLOGY, 2007, 177 (04): : 380 - 381
  • [42] FOCAL THERAPY FOR PROSTATE CANCER: DO APICAL LESIONS CORRELATE WITH WORSE OUTCOMES?
    Stabile, Armando
    Fossati, Nicola
    Gandaglia, Giorgio
    Moschini, Marco
    Macek, Petr
    Cathala, Natalie
    Cathelineau, Xavier
    Scuderi, Simone
    Robesti, Daniele
    Mazzone, Elio
    Rosiello, Giuseppe
    Bandini, Marco
    Bravi, Carlo
    Suardi, Nazareno
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Montorsi, Francesco
    Sanchez-Salas, Rafael
    JOURNAL OF UROLOGY, 2020, 203 : E1058 - E1058
  • [43] Diagnostic performance of ESUR scoring system for extraprostatic prostate cancer extension: A meta-analysis
    Li, Wei
    Dong, Anding
    Hong, Guohui
    Shang, Wenwen
    Shen, Xiaocui
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 143
  • [44] Perineural invasion as a predictor of extraprostatic extension of prostate cancer: A systematic review and meta-analysis
    Cozzi, Gabriele
    Rocco, Bernardo Maria
    Grasso, Angelica
    Rosso, Marco
    El Rahman, Davide Abed
    Oliva, Isabella
    Talso, Michele
    Costa, Beatrice
    Tafa, Ardit
    Palumbo, Carlotta
    Gadda, Franco
    Rocco, Francesco
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 (06) : 443 - 448
  • [45] Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer
    Chen, Jun-Ru
    Zhao, Jin-Ge
    Zhu, Sha
    Zhang, Meng-Ni
    Chen, Ni
    Liu, Jian-Dong
    Sun, Guang-Xi
    Shen, Peng-Fei
    Zeng, Hao
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (04) : 427 - 431
  • [46] Development and Validation of Genomic Tools to Predict Extraprostatic Extension of Prostate Cancer, Opportunities for Personalizing Treatment
    Hall, W. A.
    Liu, S.
    Fishbane, N.
    Xu, M. J.
    Davicioni, E.
    Mahal, B. A.
    Den, R. B.
    Dess, R. T.
    Jackson, W. C.
    Wong, A. C.
    Schaeffer, E. M.
    Karnes, R. J.
    Carroll, P.
    Nguyen, P. L.
    Lawton, C. A. F.
    Spratt, D. E.
    Feng, F. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S98 - S98
  • [47] Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer
    Goldberg, Hanan
    Ramiz, Abu-Hijlih
    Glicksman, Rachel
    Salgado, Noelia S.
    Chandrasekar, Thenappan
    Klaassen, Zachary
    Wallis, Christopher J. D.
    Hosni, Ali
    Moraes, Fabio Ynoe
    Ghai, Sangeet
    Kulkarni, Girish S.
    Hamilton, Robert J.
    Perlis, Nathan
    Toi, Ants
    Chung, Peter
    Evans, Andrew
    van der Kwast, Theo
    Finelli, Antonio
    Fleshner, Neil
    Berlin, Alejandro
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (01): : 88 - 96
  • [48] Preoperative prediction of multifocal prostate cancer and application of focal therapy: Review 2007
    Meiers, Isabelle
    Waters, David J.
    Bostwick, David G.
    UROLOGY, 2007, 70 (6A) : 3 - 8
  • [49] Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
    Ahmed, Hashim U.
    Hindley, Richard G.
    Dickinson, Louise
    Freeman, Alex
    Kirkham, Alex P.
    Sahu, Mahua
    Scott, Rebecca
    Allen, Clare
    Van der Meulen, Jan
    Emberton, Mark
    LANCET ONCOLOGY, 2012, 13 (06): : 622 - 632
  • [50] Focal therapy of prostate cancer
    Ganzer, R.
    Franiel, T.
    Koellermann, J.
    Kuru, T.
    Baumunk, D.
    Blana, A.
    Hadaschik, B.
    von Hardenberg, J.
    Henkel, T.
    Koehrmann, K. -U.
    Liehr, U. -B.
    Machtens, S.
    Roosen, A.
    Salomon, G.
    Schlemmer, H. -P.
    Sentker, L.
    Wendler, J.
    Witzsch, U.
    Schostak, M.
    UROLOGE, 2017, 56 (10): : 1335 - 1346